(Q34088756)

English

Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

DNA methylation

0 references

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

author name string

M Lübbert

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

P Wijermans

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

R Kunzmann

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

G Verhoef

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

A Bosly

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

C Ravoet

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

M Andre

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

A Ferrant

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

114

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

349-357

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Age-related incidence and other epidemiological aspects of myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

ICF syndrome (immunodeficiency, centromeric instability and facial anomalies): investigation of heterochromatin abnormalities and review of clinical outcome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

DNA hypomethylation leads to elevated mutation rates

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

Cytosine demethylation of the proteinase-3/myeloblastin primary granule protease gene during phagocyte development

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

Induction of differentiation and inhibition of DNA methylation in HL-60 myeloid leukemic cells by 5-AZA-2'-deoxycytidine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

The effect of 1-hydroxyvitamin D3 for prolongation of leukemic transformation-free survival in myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all- trans -retinoic acid, granulocyte colony-stimulating factor, erythropoietin and α-tocopherol

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

Growing Y-junction carbon nanotubes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02933.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2001.02933.X

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34088756&oldid=1539645488"